AIM ImmunoTech Inc

ASE:AIM

0.33

0.00 (-0.94%)

5:19:03 PM EDT: $0.32 -0.01 (-2.44%)

Market Cap (Intraday)	18.56M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$0.02 Million
Adjusted EPS	-$0.08

See more estimates

10-Day MA	$0.34
50-Day MA	$0.35
200-Day MA	$0.41

See more pivots

AIM ImmunoTech Inc Stock, ASE:AIM

2117 South West Highway 484, 2117 SW Highway 484, Ocala, Florida 34473

United States of America

Phone: +1.352.448.7797

Number of Employees: 26

http://www.aimimmuno.com

Description

AIM ImmunoTech, Inc. is a immuno-pharma company, which focuses on the research and development of therapeutics to treat multiple types of cancers, various viruses and immune-deficiency disorders. Its products include Alferon N Injection and Ampligen. The Alferon N Injection is a purified, natural source, glycosylated, multispecies alpha interferon product, composed of eight forms of high-purified alpha interferon. The Ampligen is used in the treatment of chronic fatigue syndrome and as a vaccine enhancer for therapeutic and/or preventative development related to influenza and cancer treatments. The company was founded in August 1966 and is headquartered in Ocala, FL.